Infliximab Weakens COVID Antibody Response for Patients With IBD

Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated […]
» Read morenohealthproblemsnews.com
Home »
Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated […] Overcoming the challenges in managing type 1 diabetes can sometimes feel like an unappreciated “superpower.” That was part of the […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. On the advice of its independent […]
Infliximab Weakens COVID Antibody Response for Patients With IBD
Comic Books Help Explain Type 1 Diabetes to All Ages
RECOVERY Trial of COVID Treatments Stops Colchicine Arm